(Total Views: 560)
Posted On: 08/09/2025 7:30:57 PM
Post# of 155727
Boy, given the statements in the link, wonder now, how does Novo increase demand?
$4.1 Billion investment to expand its manufacturing capacity in Clayton, North Carolina
CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories
$4.1 Billion investment to expand its manufacturing capacity in Clayton, North Carolina
CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories
Quote:
" The results of these three preclinical studies support both the biologic activity and potential clinical benefit of leronlimab’s ability to bind to CCR5 receptors on hepatic stellate cells, leading to a reversal of established liver fibrosis,” said Melissa Palmer, MD FAASLD, the Company’s Lead Consultant in Hepatology ."
(10)
(0)
